sec filing
LX
NASDAQ · LXEO
Lexeo Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$5.06
Down-$0.18 (-3.56%)
Updated Aug 22, 2026, 12:16 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 715.64M
- P/E ratio
- -3.74
- Dividend yield
- 0.00%
- 52-week range
- $3.99 – $8.00
- Volume
- 1.11M
- Avg. volume
- 1.28M
Price performance
LXEO price history
1M range · 20 trading sessions · Daily adjusted prices
LXEO closed at $5.06 after 20 trading sessions, up 8.58% for the selected period.
- Last close
- $5.06
- Period change
- +8.58%
- Period low
- $4.13
- Period high
- $5.37
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | $5.29 | $5.355 | $4.90 | $5.06 | 1.11M |
| Aug 19, 2026 | $5.07 | $5.405 | $5.05 | $5.37 | 941.95K |
| Aug 18, 2026 | $4.94 | $5.05 | $4.825 | $4.93 | 649.79K |
| Aug 17, 2026 | $4.83 | $5.0259 | $4.82 | $4.98 | 913.84K |
| Aug 14, 2026 | $4.98 | $4.98 | $4.72 | $4.84 | 676.67K |
| Aug 13, 2026 | $4.95 | $5.015 | $4.73 | $4.96 | 1.11M |
| Aug 12, 2026 | $4.84 | $5.075 | $4.70 | $4.87 | 1.63M |
| Aug 11, 2026 | $4.66 | $4.89 | $4.54 | $4.78 | 1.33M |
| Aug 10, 2026 | $4.79 | $4.85 | $4.60 | $4.63 | 722.07K |
| Aug 7, 2026 | $4.60 | $4.825 | $4.54 | $4.81 | 1.08M |
| Aug 6, 2026 | $4.57 | $4.705 | $4.40 | $4.55 | 1.46M |
| Aug 5, 2026 | $4.50 | $4.69 | $4.36 | $4.45 | 910.66K |
| Aug 4, 2026 | $4.22 | $4.49 | $4.22 | $4.41 | 917.01K |
| Aug 3, 2026 | $4.15 | $4.205 | $3.99 | $4.20 | 667.15K |
| Jul 31, 2026 | $4.38 | $4.38 | $4.07 | $4.13 | 713.57K |
| Jul 30, 2026 | $4.36 | $4.47 | $4.28 | $4.35 | 644.63K |
| Jul 29, 2026 | $4.49 | $4.49 | $4.225 | $4.31 | 848.69K |
| Jul 28, 2026 | $4.48 | $4.51 | $4.33 | $4.39 | 586.1K |
| Jul 27, 2026 | $4.70 | $4.845 | $4.40 | $4.47 | 965.6K |
| Jul 24, 2026 | $4.72 | $4.90 | $4.495 | $4.66 | 656.87K |
Latest LXEO news
The latest Smart Investors Daily articles mentioning LXEO.
Stock researchMarket Activity · Short Interest
Loading stock research…